Colfax Corporation Stock News

Wilmington, DE, April 05, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation (“Enovis” or the “Company”) (NYSE: ENOV), an innovation-driven medical technology growth company formerly known as Colfa

Wilmington, DE, March 28, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE: CFX), a leading diversified technology company which will renamed Enovis Corporation (“Enovis”) following the expecte

Bad news can be good news if you have the pattern beforehand and plan for it. There is nothing magical in how I would trade it, I have discussed hedging before.

Colfax Corp's (NYSE: CFX) price target has been lowered to $52 (an upside of 41%) from $60 by KeyBanc analyst Jeffrey Hammond, following ESAB/Enovis's 2022 Investor Day to reflect broadly lower p

Colfax Corp''s (NYSE: CFX ) price target has been lowered to $52 (an upside of 41%) from $60 by KeyBanc analyst Jeffrey Hammond, following ESAB/Enovis''s 2022 Investor Day to reflect broadly lower peer multiples. The analyst maintained an Overweight rating on CFX shares. Related : Colfax''s Q4 Earnings Morgan Stanley also lowered its price target on Colfax to $41 … Full story available on Benzinga.com

Colfax Corp's (NYSE: CFX) price target has been lowered to $52 (an upside of 41%) from $60 by KeyBanc analyst Jeffrey Hammond, following ESAB/Enovis's 2022 Investor Day to reflect broadly lower p

Wilmington DE,, March 14, 2022 (GLOBE NEWSWIRE) -- —Colfax Corporation (“Colfax”) (NYSE: CFX) today announced that its Board of Directors has declared (a) a pro rata distribution of 90% of the

Wilmington, DE, March 07, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today that it had given not

Colfax (NYSE:CFX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 3 0 0 Last 30D 0 0 0 0

Colfax (NYSE: CFX ) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 3 0 0 Last 30D 0 0 0 0 0 1M Ago 1 0 0 0 0 2M Ago 0 0 3 0 0 3M Ago 0 0 0 0 0 According to 4 analyst offering 12-month price targets in the last 3 months, Colfax has an average price target of $48.25 with a high of $52.00 and a low of $45.00. Below is a summary of how these 4 analysts rated Colfax over the past 3 months. The … Full story available on Benzinga.com

Colfax Corporation with ticker code (CFX) have now 13 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 65 and 39 with a mean TP of 52.31. With the stocks previous close at 42.48 this is indicating there is a potential upside of 23.1%. The 50 day moving average now sits at 43.35 and the 200 day moving average is 46.26. The market capitalisation for the company is $6,487m. Find out more information at: https://www.colfaxcorp.com [stock_market_widget type="chart" template="basic" color="green" assets=CFX" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $7,988m based on the market concensus. Colfax Corporation operates as a diversified technology company worldwide. The company operates in two segments, Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding, as well as gas control equipment.

Over the past 3 months, 4 analysts have published their opinion on Colfax (NYSE:CFX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's b

Over the past 3 months, 4 analysts have published their opinion on Colfax (NYSE: CFX ) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company''s business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 3 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 1 0 0 2M Ago 0 0 2 0 0 3M Ago 0 0 0 0 0 In the last 3 months, 4 analysts have offered 12-month price targets for Colfax. The company has an average price target of $48.25 with a high of $52.00 and a low of $45.00. Below is a summary of how … Full story available on Benzinga.com

Colfax's (CFX) fourth-quarter 2021 net sales increase 23.6% year over year on impressive performance across its segments.

Colfax's (CFX) fourth-quarter 2021 net sales increase 23.6% year over year on impressive performance across its segments.